U.S. federal trademark · Serial No. 75127998
pharmaceuticals, for use in the treatment of actinic keratosis, kaposi's sarcoma, basal cell carcinoma, cancers (all types, including leukemia and other blood types), sickle cell anemia, restenosis, atherosclerosis, diabetic retinopathy, arteriosclerosis, diseases characterized by neovascularization, dermatologic condition, and gastro intestinal diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.